GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract HHSN272201500014CSPERO THERAPEUTICS, INC.

Overview

Award facts

Net obligations
$5.92M
$5,923,719of $9.39M potential value
Outlays (paid to date)
$0
$0 paid of $5.92M obligated$0
Period of performance
Jun 30, 2015 to Jun 15, 2021
Ended
Modifications
19
Latest action Apr 8, 2022
Contract type
Definitive contract
PIID HHSN272201500014C

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF - "DEVELOPMENT OF A SECOND GENERATION POLYMYXIN FOR THERAPY OF MDR GRAM-NEGATIVE INFECTIONS"

Dates and value

Award date
Signed on Jun 30, 2015
Potential end of performance
Jun 14, 2021
Current value
$5,923,719Base and exercised options
Potential value (if all options are exercised)
$9,391,176

Obligations by fiscal year of action

  • FY2022: -$4,302 (de-obligation)
  • FY2019: $210,895
  • FY2018: $571,132
  • FY2017: $2,015,511
  • FY2016: $1,634,580
  • FY2015: $1,495,903

Total across 6 fiscal years: $5,923,719

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Apr 8, 2022. View on USAspending · Recipient on SAM.gov

Recipient

LocationCAMBRIDGE, MA
UEINX34PL7NZW24
CAGE code7SK81
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

Self-certified small disadvantaged businessFor-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
02139-3309 United Kingdom

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
25

Solicitation and notices

Solicitation ID
NIHAI2014007(as reported)

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Commercial procedures
Commercial item procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jun 30, 2015Base obligation at award: $1,495,903
Latest action
Apr 8, 2022 — Other administrative actionModification P00019; obligation change -$4,302; administrative: no change in scope or value
Latest substantive action
Jun 3, 2020 — Change orderModification P00015
Actions by type
  • Base award1
  • Other administrative action8
  • Supplemental agreement (within scope)7
  • Change order2
  • Option exercised1
  • Novation (contract transferred)1
20 actions recorded, Jun 30, 2015 to Apr 8, 2022; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$4,302
Latest action: change in base and all options
-$4,302

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
Yes

Place and origin

Domestic or foreign entity
Foreign-owned business not incorporated in the U.S.D
Country of product or service origin
United kingdomGBR
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
20

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2017/2017-0885-000
  • 075-2018/2018-0885-000
  • 075-2019/2019-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression